Enzyme promiscuity in earthworm serine protease: substrate versatility and therapeutic potential
- 478 Downloads
Enzymes are the most versatile molecules in the biological world. These amazing molecules play an integral role in the regulation of various metabolic pathways and physiology subsequently. Promiscuity of an enzyme is the capacity to catalyze additional biochemical reactions besides their native one. Catalytic promiscuity has shown great impact in enzyme engineering for commercial enzyme and therapeutics with natural or engineered catalytic promiscuity. The earthworm serine protease (ESP) is a classic example of enzyme promiscuity and studied for its therapeutic potential over the last few decades. The ESP was reported for several therapeutic properties and fibrinolytic activity has been much explored. ESP, a complex enzyme exists as several isoforms of molecular weight ranging from 14 to 33 kDa. The fibrinolytic capacity of the enzyme has been studied in different species of earthworm and molecular mechanism is quite different from conventional thrombolytics. Cytotoxic and anti-tumor activities of ESP were evaluated using several cancer cell lines. Enzyme had shown tremendous scope in fighting against plant viruses and microbes. ESP is also reported for anti-inflammatory activity and anti-oxidant property. Apart from these, recently, ESP is reported for DNase activity. The daunting challenge for researchers is to understand the molecular mechanism for such diverse properties and possibility of enzyme promiscuity. This review emphasizes molecular mechanism of ESP governing various biochemical reactions. Further, the concept of enzyme promiscuity in ESP towards development of novel enzyme based drugs has been reviewed in this study.
KeywordsAnti-tumor and anti-viral activity DNase Enzyme and catalytic promiscuity Earthworm serine protease (ESP) Thrombotic and vascular disorders
The authors thank the Principal and the management of R.V.R. & J.C. College of Engineering (A), Guntur, Andhra Pradesh, India, for providing support to the current study.
Compliance with ethical standards
Conflict of interest
Author declares no conflict of interest.
- Cong Y, Liu Y, Chen JC (2000) Advance in lumbrokinase. Chin J Biochem Pharm 21:159–162Google Scholar
- He DW, Zhou F (2005) Study on the anti-tumor effects of earthworm extract. J Yangtze Univ (Nat Sci Edit) 18:225–228Google Scholar
- Hong C, Takahashi S, Imamura M et al (2007) Earthworm fibrinolytic enzyme- anti-tumor activity on human hepatoma cells in vitro and in vivo. Chin Med J 120(10):898–904Google Scholar
- Jeon OH, Moon WJ, Kim DS (1995) An anticoagulant/fibrinolytic protease from Lumbricus rubellus. J Biochem Mol Biol 28:138–1452Google Scholar
- Mao S, Yan Z, Chen S (2000) Purification and kinetic characteristics of fibrinolytic enzymes from earthworm. J Wenzhou Med Coll 30:277–278Google Scholar
- Michael JE, Benjamin FC (2006) Mechanism-based profiling of enzyme families. Chem Rev A23-T. 10.1021/cr050288g
- Mihara H, Sumi H, Akazawa K (1983) Fibrinolytic enzyme extracted from the earthworm. Thromb Haemost 50(3):258Google Scholar
- Park SY, Kye KC, Lee M (1989) Fibrinolytic activity of the earthworm extract. Thromb Haemosta 62:545–550Google Scholar
- Xie JB, He WG, Weng N et al (2003) Extraction and isolation of the anti-tumor protein components from earthworm (Eisenia fetida andrei) and the anti-tumor activity. Chin J Bio Mol Biol 19:359–366Google Scholar
- Yang JS, Ru BG (1998) Degradation of N-acetyl-l-tyrosine ethyl ester (ATEE) by a plasminogen activator from Eisenia fetida (e-PA). Chin J Biochem Mol Biol 14:417–421Google Scholar
- Yegnanarayan R, Sethi PP, Rajhans PK et al (1987) Anti-inflammatory activity of total earthworm extracts in rats. Ind J Pharm 19:221–224Google Scholar
- Yegnanarayan R, Ismail SA, Shorti DS (1998) Anti-inflammatory activity of two earthworm portions in carrageenan pedal oedema test in rats. Ind J Physiol Pharmacol 32:72–74Google Scholar
- Yuan L, Xu JM, Zhou YC (2004) Effects of the purified earthworm extracts on various hemal tumor cells. Clin Med J China 11:177–179Google Scholar
- Zhang X, Zhang J, Kuang P et al (2003) The effect of lumbrokinase on P-selectin and E-selectin in cerebral ischemia model of rat. J TraditChin Med 23:141–146Google Scholar
- Zhao J, Pan R, He J, et al (2007) Eisenia fetida protease-III-1 functions in both fibrinolysis and fibrogenesis. J of Biomed Biotechnol 2007, Article ID 97654Google Scholar
- Zhu Y, He ZZ, Sun KD, Wang SF (2000) Effect of lumbrokinase on experimental thrombus. J Chin Pharm Univ 31:50–52Google Scholar